Correlation Between ATT and Genscript Biotech
Can any of the company-specific risk be diversified away by investing in both ATT and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Genscript Biotech, you can compare the effects of market volatilities on ATT and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Genscript Biotech.
Diversification Opportunities for ATT and Genscript Biotech
0.64 | Correlation Coefficient |
Poor diversification
The 3 months correlation between ATT and Genscript is 0.64. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of ATT i.e., ATT and Genscript Biotech go up and down completely randomly.
Pair Corralation between ATT and Genscript Biotech
Taking into account the 90-day investment horizon ATT Inc is expected to generate 0.29 times more return on investment than Genscript Biotech. However, ATT Inc is 3.47 times less risky than Genscript Biotech. It trades about 0.12 of its potential returns per unit of risk. Genscript Biotech is currently generating about 0.02 per unit of risk. If you would invest 1,259 in ATT Inc on April 24, 2025 and sell it today you would earn a total of 1,483 from holding ATT Inc or generate 117.79% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 98.6% |
Values | Daily Returns |
ATT Inc vs. Genscript Biotech
Performance |
Timeline |
ATT Inc |
Genscript Biotech |
ATT and Genscript Biotech Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with ATT and Genscript Biotech
The main advantage of trading using opposite ATT and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.ATT vs. Media Technologies | ATT vs. Voya Infrastructure Industrials | ATT vs. Surge Components | ATT vs. Morningstar Unconstrained Allocation |
Genscript Biotech vs. Innovent Biologics | Genscript Biotech vs. Telix Pharmaceuticals Limited | Genscript Biotech vs. Keros Therapeutics | Genscript Biotech vs. MAIA Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
CEOs Directory Screen CEOs from public companies around the world | |
Share Portfolio Track or share privately all of your investments from the convenience of any device |